Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scott Morenstein Insider Profile
11 Followers
Scott Morenstein, Director at Celator Pharmaceuticals, holds 2.05M shares in Molecular Templates (Ticker: MTEM), holds 6.28K shares in Celator Pharmaceuticals (Ticker: CLPM), holds 17.86K shares in Madrigal Pharmaceuticals (Ticker: MDGL). Most recently, Scott Morenstein Bought ― shares of Molecular Templates on Nov 25, 2019 for an estimated value of 3.75M.
Scott Morenstein Celator Pharmaceuticals (CLPM)Director
Celator Pharmaceuticals (CLPM)
Director
Ranked #47,428 out of 98,743 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+3.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Scott Morenstein holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 27, 2018 - Sep 27, 2019
Return:+23.90%
The most profitable trade made by Scott Morenstein
Scott Morenstein's Trading History
Celator Pharmaceuticals
Jul 12, 2016
―
Uninformative Sell
31.62M
$189.82K
Molecular Templates
Nov 25, 2019
Director
Informative Buy
3.75M
$3.28M
Madrigal Pharmaceuticals
Jan 05, 2016
Director
Uninformative Buy
―
$3.71M
List of latest transactions for each holding click on a transaction to see Scott Morenstein's performance on stock
You May Also Like
Scott Morenstein insider profile FAQ
What is the percentage of profitable transactions made by Scott Morenstein?
The percentage of profitable transactions made by Scott Morenstein is 50%.
What is the average return per transaction made by Scott Morenstein?
The average return per transaction made by Scott Morenstein is 3.20%.
What stocks does Scott Morenstein hold?
Scott Morenstein holds: CLPM, MTEM, MDGL stocks.
What was Scott Morenstein’s latest transaction?
Scott Morenstein latest transaction was an Informative Buy of $3.75M.
What was Scott Morenstein's most profitable transaction?
Scott Morenstein’s most profitable transaction was an Informative Buy of MTEM stock on September 27, 2018. The return on the trade was 23.90%.
What is Scott Morenstein's role in Celator Pharmaceuticals?
Scott Morenstein's role in Celator Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.